{"id":67,"date":"2009-04-02T11:21:14","date_gmt":"2009-04-02T19:21:14","guid":{"rendered":"http:\/\/blogs.edf.org\/nanotechnology\/2009\/04\/02\/reaching-for-nano\/"},"modified":"2024-02-12T11:00:41","modified_gmt":"2024-02-12T16:00:41","slug":"reaching-for-nano","status":"publish","type":"post","link":"https:\/\/blogs.edf.org\/health\/2009\/04\/02\/reaching-for-nano\/","title":{"rendered":"REACHing for nano"},"content":{"rendered":"<p><em>Richard Denison, Ph.D., is a Senior Scientist.<\/em><\/p>\n<p>In a <a href=\"http:\/\/blogs.edf.org\/nanotechnology\/2008\/07\/28\/fixing-tsca-for-nano-dont-forget-all-the-other-chemicals\/\">previous post<\/a>, I argued that the European Union&#8217;s REACH Regulation for chemicals goes a long way to address the regulatory needs for nanomaterials &#8211; despite the fact that REACH never mentions nano and was not developed with nano in mind.\u00a0 I also noted, however, that REACH will clearly need more than fine-tuning to ensure adequate nano oversight.\u00a0 Apparently at least some in the European Parliament agree.\u00a0 <!--more--><\/p>\n<p>Just this week, the <a href=\"http:\/\/www.europarl.europa.eu\/activities\/committees\/homeCom.do?language=EN&amp;body=ENVI\">Environment Committee of the European Parliament<\/a> approved a report calling for a nano-specific review and updating of REACH. \u00a0(See the <a href=\"http:\/\/www.endseurope.com\/docs\/90331a.doc\">amendments<\/a> that were adopted this week to the <a href=\"http:\/\/www.europarl.europa.eu\/meetdocs\/2004_2009\/documents\/pr\/763\/763225\/763225en.pdf\">January draft report<\/a>.)<\/p>\n<p>Most notable is the report&#8217;s call to extend the &#8220;no data, no market&#8221; cornerstone of REACH to nanomaterials &#8211; meaning that nanomaterials could not enter or remain on the market absent provision by their producers of at least basic information to assess their safety.<\/p>\n<p>The report also calls for the development under REACH of nano-specific definitions, testing and assessment protocols, and data requirements.\u00a0 And it argues for labeling of products containing nanomaterials.<\/p>\n<p>The report comes not long after the <a href=\"http:\/\/ec.europa.eu\/enterprise\/newsroom\/cf\/itemshortdetail.cfm?item_id=2809\">European Commission issued its own recommendations<\/a> for how to address nanomaterials under REACH.\u00a0 While the Commission noted numerous challenges &#8211; most notably, the dearth of safety data and the difficulty of applying current risk assessment methodology &#8211; it argued that REACH addresses the potential risks of nanomaterials &#8220;in principle.&#8221; \u00a0Looking at the same basic problems, the Parliament report reaches the opposite conclusion:\u00a0 that REACH cannot in its current form adequately address nanomaterials.<\/p>\n<p>Changes to REACH that the Parliament committee recommends include requiring:<\/p>\n<ul>\n<li>a simplified registration for nanomaterials manufactured or imported (with a threshold based on e.g. surface activity instead of tonnage), providing core data on physico-chemical properties as well as toxicological and ecotoxicological effects,<\/li>\n<li>a chemical safety report with exposure assessment for all registered nanomaterials, irrespective of hazard identification, and<\/li>\n<li>notification for all nanomaterials placed on the market on their own, in preparations or in articles irrespective of tonnage and concentration thresholds.<\/li>\n<\/ul>\n<p>See these articles from <a href=\"http:\/\/www.euractiv.com\/en\/science\/data-market-nanotechnologies-meps\/article-180893\">Euractiv<\/a>, <a href=\"http:\/\/www.endseurope.com\/21046?referrer=news\">ENDSEurope<\/a> and <a href=\"http:\/\/chemicalwatch.com\/2008\">ChemicalWatch<\/a> for more detail and document links (the last two require subscriptions).<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Richard Denison, Ph.D., is a Senior Scientist. In a previous post, I argued that the European Union&#8217;s REACH Regulation for chemicals goes a long way to address the regulatory needs for nanomaterials &#8211; despite the fact that REACH never mentions nano and was not developed with nano in mind.\u00a0 I also noted, however, that REACH &#8230;<\/p>\n","protected":false},"author":100,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[44,56087],"tags":[39153,446],"coauthors":[],"class_list":["post-67","post","type-post","status-publish","format-standard","hentry","category-policy","category-nanotechnology","tag-data-requirements","tag-reach"],"acf":[],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/blogs.edf.org\/health\/wp-json\/wp\/v2\/posts\/67","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/blogs.edf.org\/health\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blogs.edf.org\/health\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blogs.edf.org\/health\/wp-json\/wp\/v2\/users\/100"}],"replies":[{"embeddable":true,"href":"https:\/\/blogs.edf.org\/health\/wp-json\/wp\/v2\/comments?post=67"}],"version-history":[{"count":1,"href":"https:\/\/blogs.edf.org\/health\/wp-json\/wp\/v2\/posts\/67\/revisions"}],"predecessor-version":[{"id":12526,"href":"https:\/\/blogs.edf.org\/health\/wp-json\/wp\/v2\/posts\/67\/revisions\/12526"}],"wp:attachment":[{"href":"https:\/\/blogs.edf.org\/health\/wp-json\/wp\/v2\/media?parent=67"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blogs.edf.org\/health\/wp-json\/wp\/v2\/categories?post=67"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blogs.edf.org\/health\/wp-json\/wp\/v2\/tags?post=67"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/blogs.edf.org\/health\/wp-json\/wp\/v2\/coauthors?post=67"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}